Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

The criteria help doctors diagnose and treat alopecia areata more effectively.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Dermatological diseases affect women's work performance more than men's.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Hair loss lowers young men's self-esteem, increasing social anxiety and affecting daily life.

Women with PCOS tend to be less optimistic than those without it.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Diseases have a big social impact in Nordic countries, affecting healthcare decisions.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Hirsutism moderately affects the quality of life for most women, linked to condition severity.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Personality traits significantly affect the onset, progression, and psychological impact of alopecia areata.

Nearly half of the patients had Long COVID, leading to health and work issues, especially in high-risk groups.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Thyroid disorders significantly affect the well-being of married, urban, non-working individuals in South India.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Ayurvedic treatment improved PCOS symptoms and hormone levels.

Hair loss and mental health issues like anxiety and insomnia affect each other, impacting quality of life.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

Hormonal balance is vital for women's health and performance, but therapies like contraceptives and steroids have both benefits and risks.

Alopecia areata patients have lower vitamin D and slightly lower copper levels, so these should be checked.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.